Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2026-02-06 @ 12:56 PM
Study NCT ID:
NCT02379195
Status:
COMPLETED
Last Update Posted:
2020-01-22
First Post:
2015-02-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Peginterferon and TIL Therapy for Metastatic Melanoma
Sponsor:
Inge Marie Svane
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MM1413
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None